Skip to main content
. 2021 Apr 26;10(9):e019125. doi: 10.1161/JAHA.120.019125

Figure 5. Changes in biochemical markers in all patients with inflammatory bowel disease.

Figure 5

hs‐CRP indicates high‐sensitivity C‐reactive protein; IL‐6, interleukin‐6; and TNF‐α, tumor necrosis factor‐α.